These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 14208046)

  • 41. [A survey of the knowledge, attitude and practice toward measles and measles vaccine of mothers in Cheng-Chung district].
    Chern HT; Liao CN; Kwo SY
    Hu Li Za Zhi; 1974 Apr; 21(2):30-8. PubMed ID: 4497867
    [No Abstract]   [Full Text] [Related]  

  • 42. Measles mortality reduction in West Africa, 1996-2002.
    Wkly Epidemiol Rec; 2003 Nov; 78(45):390-2. PubMed ID: 14631596
    [No Abstract]   [Full Text] [Related]  

  • 43. THE FUTURE OF MEASLES VACCINATION.
    WALLGREN A
    Arch Gesamte Virusforsch; 1965; 16():367-74. PubMed ID: 14322898
    [No Abstract]   [Full Text] [Related]  

  • 44. Kwashiorkor--is it a dying disease?
    Oyelami OA; Ogunlesi TA
    S Afr Med J; 2007 Jan; 97(1):65-8. PubMed ID: 17378286
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [MEASLES--EPIDEMIOLOGICAL CONSIDERATIONS IN RELATION TO MASS VACCINATION].
    HEIDE T
    Nord Med; 1963 Nov; 70():1215-20. PubMed ID: 14101094
    [No Abstract]   [Full Text] [Related]  

  • 46. Potency status and efficacy of measles vaccine administered in Nigeria: a case study of three EPI centres in Lagos, Nigeria.
    Omilabu SA; Oyefolu AO; Ojo OO; Audu RA
    Afr J Med Med Sci; 1999; 28(3-4):209-12. PubMed ID: 11205835
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MEASLES VACCINE FIELD TRIALS IN ALASKA. II. VACCINATION ON ST. PAUL ISLAND, PRIBILOFS, WHERE MEASLES HAD BEEN ABSENT FOR 21 YEARS.
    BRODY JA; EMANUEL I; MCALISTER R; ALEXANDER ER
    JAMA; 1964 Dec; 190():965-8. PubMed ID: 14214518
    [No Abstract]   [Full Text] [Related]  

  • 48. [Clinical characteristics of reactions of children to measles vaccination and course of measles in vaccinated children].
    Stepina NG; Kravchenko AS; Onishchenko TE; Shlifer RN; Cheaureli EP
    Tr Leningr Nauchnoissled Inst Epidemiol Mikrobiol; 1965; 28():230-4. PubMed ID: 5860944
    [No Abstract]   [Full Text] [Related]  

  • 49. [REVIEW OF DATA CONCERNING THE EPIDEMIOLOGY AND ETIOLOGY OF MEASLES AND AIDS FOR VACCINATION AGAINST THE DISEASE].
    VERONESI R; SCHMID AW; MOURARDE A; CARVALHO RP; ZUCCAS WA; CAMARGO M
    Arq Fac Hig Saude Publica Univ Sao Paulo; 1963 Dec; 17():135-204. PubMed ID: 14126030
    [No Abstract]   [Full Text] [Related]  

  • 50. [Results of the use of the Leningrad-4 live measles vaccine during increasing measles morbidity].
    Revenok ND; Smorodintsev AA
    Tr Leningr Nauchnoissled Inst Epidemiol Mikrobiol; 1965; 28():361-71. PubMed ID: 5860954
    [No Abstract]   [Full Text] [Related]  

  • 51. A further study on measles vaccination in Nigerian children.
    Hendrickse RG; Montefiore D; Sherman PM; Sofoluwe GO
    Bull World Health Organ; 1965; 32(6):803-8. PubMed ID: 5294305
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Reactogenic properties of the live measles vaccine of the Pasteur Institute of Epidemiology and Microbiology in Leningrad].
    Reviia GS; Safarov DI; Aĭbinder SL
    Tr Leningr Nauchnoissled Inst Epidemiol Mikrobiol; 1965; 28():157-65. PubMed ID: 5860937
    [No Abstract]   [Full Text] [Related]  

  • 53. [Nature of reactogenic properties of the measles vaccine of the Pasteur Institute of Epidemiology and Microbiology in Leningrad].
    Netsvetaeva TD
    Tr Leningr Nauchnoissled Inst Epidemiol Mikrobiol; 1965; 28():222-4. PubMed ID: 5860942
    [No Abstract]   [Full Text] [Related]  

  • 54. Differences in female-male mortality after high-titre measles vaccine and association with subsequent vaccination with diphtheria-tetanus-pertussis and inactivated poliovirus: reanalysis of West African studies.
    Aaby P; Jensen H; Samb B; Cisse B; Sodemann M; Jakobsen M; Poulsen A; Rodrigues A; Lisse IM; Simondon F; Whittle H
    Lancet; 2003 Jun; 361(9376):2183-8. PubMed ID: 12842371
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mass measles control in West and Central Africa.
    Foster SO; Pifer JM
    Afr J Med Sci; 1971 Apr; 2(2):151-8. PubMed ID: 5111614
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Reactivity and epidemiological effectiveness of the measles vaccine of the Leningrad Pasteur Institute of Epidemiology and Microbiology in Baku].
    Safarov DM; Reviia GS
    Tr Leningr Nauchnoissled Inst Epidemiol Mikrobiol; 1965; 28():330-4. PubMed ID: 4222061
    [No Abstract]   [Full Text] [Related]  

  • 57. [Results of the use of the live measles vaccine of the Leningrad Pasteur Institute of Epidemiology and Microbiology in Alma-Ata].
    Rozhnov VF
    Tr Leningr Nauchnoissled Inst Epidemiol Mikrobiol; 1965; 28():388-94. PubMed ID: 4221935
    [No Abstract]   [Full Text] [Related]  

  • 58. A CONTROLLED TRIAL OF LIVER-VIRUS VACCINE AGAINST MEASLES IN CHILE.
    RISTORI C; BOCCARDO H; MIRANDA M; BORGONO M
    Bull World Health Organ; 1964; 30(6):763-8. PubMed ID: 14215183
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Measles Cases during Ebola Outbreak, West Africa, 2013-2106.
    Colavita F; Biava M; Castilletti C; Quartu S; Vairo F; Caglioti C; Agrati C; Lalle E; Bordi L; Lanini S; Guanti MD; Miccio R; Ippolito G; Capobianchi MR; Di Caro A;
    Emerg Infect Dis; 2017 Jun; 23(6):1035-1037. PubMed ID: 28518027
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Result of the anti-measles immunization with the live vaccine of the Leningrad Pasteur Institute of Epidemiology and Microbiology in Kharkov].
    Kiselev RI; Shulichenko AI; Korabel'nikova AI; Khokhlova SM
    Tr Leningr Nauchnoissled Inst Epidemiol Mikrobiol; 1965; 28():395-400. PubMed ID: 5860957
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.